Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

England is deep into its third lockdown, yet the daily tally of new COVID cases and deaths remains sickeningly high. As Chris Whitty, the country’s chief medical officer, said recently, more needs to be done to bring the pandemic under control.

Masks, which when worn correctly are highly effective in reducing transmission, are already compulsory in indoor public places in the UK. There is talk of making them mandatory in some outdoor settings, as is currently the case in Spain. Perhaps the UK should follow France and require people who are jogging or cycling to wear masks if they are unable to maintain a physical distance from pedestrians.

There are many arguments against such a measure. The risk of transmitting coronavirus outdoors is an order of magnitude less than indoors, according to a study that has yet to be published in a scientific journal. Exercising outdoors is one of the few freedoms people in England still have. When jogging or cycling, contacts tend to be rare and fleeting, so would not meet the UK’s official definition of a “close contact” for which one needs to spend 15 minutes closer than two metres – though this time period can now be notched up in a series of shorter encounters throughout a day.

Read the full article on The Conversation website, written by Professor Trish Greenhalgh, Nuffield Department of Primary Care Health Sciences.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Five ways the pandemic has affected routine medical care

Since the beginning of the pandemic, COVID has infected at least a third of the UK population and is estimated to have factored in the deaths of almost 200,000 people in the UK. But critically, COVID has also had a devastating impact on our healthcare systems. While this was expected, new evidence is beginning to reveal the scope of the issue – in particular the effects for people living with long-term health conditions.

Clinical trials for a malaria vaccine start in Mali and Indonesia

Sanaria Inc. announced that two new Phase 2 trials of its pioneering malaria vaccines have started. The first is in 6- to 10-year-old children living in Bancoumana, Mali, a malarious region of West Africa. The second is in Indonesian soldiers based in Sumatra, Indonesia. The soldiers will be deploying for six to nine months this coming August to an intensely malarious district in eastern Indonesia.

Mechanism of expanding bacteria revealed

A new study published in Nature has identified a potential Achilles heel in the protective layers surrounding Gram-negative bacteria that could aid in the development of next-generation antibiotics.

Oxford to receive £7 million to turn bright ideas into global opportunities

The University of Oxford has been awarded more than £7 million, the highest amount of funding given to organisations across the UK, in the latest round of UK Research and Innovation’s (UKRI) Impact Acceleration Account (IAA) funding - aimed at fueling the best, brightest and most disruptive ideas from Uk research institutions.

Discovery of gene involved in chronic pain creates new treatment target

Oxford researchers have discovered a gene that regulates pain sensitisation by amplifying pain signals within the spinal cord, helping them to understand an important mechanism underlying chronic pain in humans and providing a new treatment target.

Oxford's largest ever study into Varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications establishes for the first time, a critical genetic risk score to predict the likelihood of patients suffering with Varicose veins to require surgery, as well as pointing the way towards potential new therapies.